Artivion | CRY - Equity Capital And Reserves


Artivion reported $448.23M in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Abbott USD 52.13B 1.3B Dec/2025
Accuray USD 61.87M 19.3M Sep/2025
AngioDynamics USD 176.33M 2.52M Sep/2025
Artivion USD 448.23M 9.54M Dec/2025
AtriCure USD 491.94M 15.43M Dec/2025
Baxter International USD 6.13B 1.11B Dec/2025
Becton, Dickinson and Co. USD 25.28B 108M Dec/2025
Boston Scientific USD 24.23B 1.58B Dec/2025
Edwards Lifesciences USD 10.2B 340.3M Sep/2025
Inogen USD 197.18M 2.32M Sep/2025
Integra LifeSciences USD 1.04B 5.89M Dec/2025
J&J USD 78.47B 0 Sep/2025
Mesa Laboratories USD 186.69M 8.22M Dec/2025
Orthofix International USD 450.04M 7.55M Dec/2025
Pfizer USD 92.8B 4.11B Sep/2025
ResMed USD 6.32B 199.61M Dec/2025
Stryker USD 21.78B 594M Sep/2025
Surmodics USD 111.31M 7.59M Jun/2025
Tandem Diabetes Care USD 155.17M 22.2M Dec/2025
Teleflex USD 3.12B 697.09M Dec/2025
Terumo JPY 1.52T 84.79B Dec/2025
Trinity Biotech USD -54.72M 5.18M Sep/2025